Viral Gastroenteritis Market to Reach $8.69 Billion by 2029, Growing at a CAGR of 5.3%

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Viral Gastroenteritis Industry Expected To Reach By 2029, Starting From 2025 Levels?

The market for viral gastroenteritis has experienced steady expansion in recent years. Forecasts indicate it will increase from $6.75 billion in 2024 to $7.06 billion in 2025, driven by a compound annual growth rate (CAGR) of 4.7%. Historically, this growth has been fueled by several key factors, including the widespread presence of viral infections, global hygiene practices, advancements in diagnostic techniques, international travel and tourism, and various climatic and environmental elements.

The viral gastroenteritis market size is projected to demonstrate significant expansion in the coming years. It is anticipated to increase to $8.69 billion by 2029, achieving a compound annual growth rate (CAGR) of 5.3%. The growth during the forecast period is fueled by elements such as global health preparedness, the effects of climate change, the adoption of a one health approach, advanced epidemiological surveillance systems, and improved education and public awareness. Prominent trends for the forecast period include the development of vaccines, sophisticated diagnostic tools, the utilization of telemedicine in diagnosis, cooperative research initiatives, tailored medicine approaches, and digital health solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

What Are The Main Drivers Boosting The Viral Gastroenteritis Industry’s Expansion?

The rising incidence of gastrointestinal disorders is projected to propel the expansion of the viral gastroenteritis market moving forward. Gastrointestinal (GI) disorders encompass any disease occurring within or on parts of the gastrointestinal tract. Viral gastroenteritis drugs and diagnostic treatments offer appropriate medication and care to those suffering from the illness. For instance, in September 2023, according to the IBD Clinical and Research Centre’s Impact of IBD Report 2023, a Canadian organization focused on improving the lives of patients with Crohn’s disease and ulcerative colitis, over 320,000 people in Canada had inflammatory bowel disease (IBD), with a prevalence of 825 per 100,000 in 2023. With this prevalence expected to increase by 2.44% annually, it is anticipated that 1.1% of the population, or 470,000 Canadians, will be living with IBD by 2035. Therefore, the growing prevalence of gastrointestinal disorders is stimulating growth in the viral gastroenteritis market.

What Are The Major Segment Categories Driving The Viral Gastroenteritis Market Growth?

The viral gastroenteritismarket covered in this report is segmented –

1) By Drugs: Antibiotics; Antacids; Laxatives; Antimotility Agents; Others Drugs

2) By Diagnosis: Physical Examination; Rapid Stool Test

3) By Indication: Watery Diarrhea; Abdominal Cramps; Pain; Other Indications

4) By Type Of Virus: Norovirus; Rotavirus; Astrovirus; Enteric Adenovirus

5) By End User: Hospitals; Clinics; Pharmaceutical Companies; Diagnostic Centers; Ambulatory Care Centers; Others End Users

Subsegments:

1) By Antibiotics: Broad-Spectrum Antibiotics; Narrow-Spectrum Antibiotics; Penicillins; Macrolides; Cephalosporins

2) By Antacids: Proton Pump Inhibitors (PPIs); Histamine-2 Receptor Antagonists (H2 Blockers); Magnesium-Based Antacids; Calcium-Based Antacids; Sodium Bicarbonate

3) By Laxatives: Bulk-Forming Laxatives; Osmotic Laxatives; Stimulant Laxatives; Stool Softeners

4) By Antimotility Agents: Loperamide; Diphenoxylate

5) By Other Drugs: Oral Rehydration Salts (Ors); Zinc Supplements; Antiemetics

How Are Trends Influencing The Viral Gastroenteritis Market?

Product innovation stands out as a key trend gaining popularity in the viral gastroenteritis market. Major companies operating in the viral gastroenteritis market are dedicated to developing new products to strengthen their position. For instance, in November 2022, GlaxoSmithKline PLC, a UK-based biopharmaceutical company, received approval from the US Food and Drug Administration (FDA) for its oral-dosing applicator-only presentation (liquid formulation) of ROTARIX, intended to prevent rotavirus gastroenteritis in infants. This new presentation formulation provides increased convenience for healthcare providers by eliminating the need to reconstitute the vaccine dose at the point of use. The approval is supported by international clinical trial data demonstrating safety and tolerability when compared to the lyophilized formulation, and non-inferiority of immunogenicity.

Who Are The Core Companies Influencing The Viral Gastroenteritis Market Landscape?

Major companies operating in the viral gastroenteritis market include Pfizer Inc., Abbvie Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics Plc, Dr. Reddy’s Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, Ironwood Pharmaceuticals Inc, ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan plc, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

Which Geographies Are Emerging As Strong Markets For The Viral Gastroenteritis Industry?

North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Viral Gastroenteritis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12127&type=smp

Browse Through More Reports Similar to the Global Viral Gastroenteritis Market 2025, By The Business Research Company

Forklift Truck Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/forklift-truck-global-market-report

Point Of Sale Terminals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-sale-terminals-global-market-report

Warehouse Execution System Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/warehouse-execution-system-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795